FluVaxView webpage report posted online October 25, 2018
Influenza (flu) vaccination is the primary way to prevent sickness and death caused by flu. The Advisory Committee on Immunization Practices (ACIP) recommends annual flu vaccination for all persons aged ≥6 months who do not have contraindications to vaccination.(1) The 2017–18 flu season was a high severity season with high levels of outpatient clinic and emergency department visits for flu-like illness, high flu-related hospitalization rates, and elevated and geographically widespread flu activity across the United States for an extended period.(2) The Centers for Disease Control and Prevention (CDC) analyzed data from the Behavioral Risk Factor Surveillance System (BRFSS) to estimate flu vaccination coverage for the U.S. population of adults aged ≥18 years during the 2017–18 flu season. Flu vaccination coverage among adults was 37.1%, a decrease of 6.2 percentage points from the previous flu season. Vaccination coverage varied by age group and state, and coverage decreased in all age groups and in most states. However, interpretation of these results should take into account limitations of the survey, including reliance on self-report of vaccination status and decreasing response rates. Preliminary estimates from other data sources do not show decreases in flu vaccination coverage. To improve flu vaccination coverage for the 2018–19 flu season, healthcare providers are encouraged to strongly recommend and offer flu vaccination to all of their patients. People not visiting a provider during the flu season have many convenient places they can go for a flu vaccination.
For this report, CDC analyzed data from BRFSS for adults aged ≥18 years to estimate flu vaccination coverage from the 2017-18 flu season. Estimates for children for the 2017-18 season have been published.(3) BRFSS data were collected from September 2017 through June 2018 from all 50 states to estimate vaccination coverage for vaccines administered from July 2017 through May 2018. Estimates for the District of Columbia represent vaccination coverage through November 2017 based on interviews conducted September through December 2017. The 2017-18 flu season estimates were compared with 2016–17 flu season estimates.
The state-based BRFSS is an ongoing, landline and cellular telephone survey which collects information on health conditions and risk behaviors from randomly selected adults aged ≥18 years in the U.S. population. BRFSS included survey questions asking whether the respondent had received a flu vaccination in the past 12 months, and if so, in which month and year. Responses to the flu vaccination status questions were not verified by medical records. The survey question varied in placement within the overall survey instrument between 2017 and 2018, with the flu vaccination questions being near the end of the instrument in 2017 and near the beginning in 2018. The median state BRFSS response rate for a complete or partially complete interview was 45.8% for September–December 2017 and 49.7% for January–June 2018.
Flu vaccination coverage estimates were calculated using Kaplan-Meier survival analysis to determine the cumulative flu vaccination coverage (≥1 dose) during July 2017 through May 2018 using monthly interview data collected September 2017 through June 2018. Respondents who did not have either a yes or no response to the flu vaccination status question were excluded from the analysis; this included 0.3% who reported they did not know, 0.1% who refused to answer the question, and 6.2% who most likely ended the interview before the flu question was asked. For 6.6% of BRFSS participants who indicated they had been vaccinated but had a missing month and year of vaccination, the month of vaccination was imputed from donor pools matched for week of interview, age group, state of residence, and race/ethnicity. Information on high-risk conditions was missing for 1.2% of adults and were not included in the estimates by risk condition. All estimates were weighted to the U.S. adult population with analysis conducted using SAS and SUDAAN statistical software to account for the complex survey design. Differences between groups and between 2016–17 and 2017–18 seasons were determined using t-tests with significance at p<0.05. Differences mentioned in this report were statistically significant.
Among adults aged ≥18 years, coverage was 37.1%, 6.2 percentage points lower than coverage during the 2016–17 season (43.3%; Figure 1).
Coverage for 2017-18 was lower for every age group compared to the 2016–17 season (Figure 2). For all adult age groups, flu vaccination coverage estimates in the 2017–18 season were at their lowest levels compared with the seven prior flu seasons. For the 2017-18 season, flu vaccination coverage increased with age, from 26.9% among adults 18-49 years to 59.6% among adults ≥65 years (Figure 2).
There was large between-state variability in flu coverage among adults, ranging from 29.2% in Louisiana to 46.3% in West Virginia (Figure 3). The decrease in coverage among adults for 2017-18 compared to 2016-17 occurred in 37 states; in 13 states and DC the coverage did not change from the last season.
Among adults, coverage during the 2017–18 season decreased for all racial/ethnic groups compared with the 2016–17 season except for American Indian/Alaska Natives (Table 1). Similar to the 2016–17 season, significant differences in flu vaccination coverage were observed between racial/ethnic groups: Non-Hispanic white adults and Asian adults had higher coverage than all other racial/ethnic groups; Hispanic adults had lower flu vaccination coverage than all other racial/ethnic groups.
Among adults, 78% of vaccinations during the 2017–18 season had been received by the end of November, similar to the 2016–17 season (77%) (Figure 4). Coverage by end of November 2017 was 3.0 percentage points lower than by end of November 2016; by end of January 2018, coverage was 5.5 percentage points lower compared with January 2017.
Vaccination coverage among adults during the 2017–18 season remains low, at only 37.1%. Survey data indicated a six-percentage point drop in coverage compared with the 2016–17 season; however, preliminary estimates from several other data sources did not show a similar decrease in coverage and there are limitations of the BRFSS estimates as described below. We assessed consistency of the change in the BRFSS estimates compared to the prior season with other currently available data sources. Flu vaccination coverage in the past 12 months among adults ≥18 years based on National Health Interview Survey (NHIS) data from the first quarter of 2018 was 43.8%, similar to 44.8% from 2017 first quarter data.(4) Flu vaccination coverage estimates for vaccinations received through mid-November of the flu season from the National Internet Flu Survey were similar for 2016–17 (39.8%) and 2017–18 (38.6%) Additionally, Medicare fee for service claims did not indicate a decrease in flu vaccine claims filed during the 2017–18 flu season (personal communication, Jeff Kelman, Centers for Medicare and Medicaid Services, 8/24/18). Preliminary estimates from these three data sources did not show a decrease or magnitude of decrease seen with BRFSS data. These findings should be interpreted with caution, however. Differences in the precision of estimates and survey methods (including different sampling frames, survey mode, survey questions, order of survey questions, interview period, operations, response rates, and weighting) might lead to different estimates. Some flu vaccinations received by Medicare beneficiaries may not be billed to Medicare, and data are only available for the Medicare fee for service population, which is not representative of the general adult population. Further analyses are needed to assess the final season estimates based on the NHIS when data are available in mid-2019. CDC is also exploring other potential non-survey data sources to track flu vaccination coverage.
Despite potential limitations of all of the mentioned data sources, flu vaccination coverage among adults remains low with only about 4 in 10 adults reporting receipt of a flu vaccination, as reported for the past eight flu seasons (Figure 1). As the 2018–19 season is underway, it is important that providers prioritize flu vaccination for their patients. This includes client reminders when flu vaccine supplies become available, assessing the vaccination status at every visit, making an effective recommendation for vaccination, and offering the vaccine. For more information about flu, including flu vaccine recommendations, flu activity and surveillance, and resources for discussing flu vaccination with patients, visit the CDC flu webpage.